Allergychoices LLC

Allergychoices LLC is an allergist in Onalaska, WI. The practice provides sublingual immunotherapy, also known as allergy drops, which treat the cause of allergic disease rather than only managing symptoms. The allergy drops address a wide range of allergies and related conditions, including asthma, dust mite allergy, eczema, EoE, food allergy, grass allergy, mold allergy, oral allergy syndrome, pet allergy, sinusitis, tree allergy, and weed allergy. Treatment options include environmental allergy treatment, food allergy treatment, and preseasonal allergy treatment. The practice holds a rating of 4.60.

Founded in 2000, Allergychoices began as a dedicated education, advocacy, and networking resource for patients and providers interested in treating the cause of allergic disease with sublingual immunotherapy. The organization works with providers to integrate custom, patient-specific sublingual immunotherapy into their practices, and also partners with employer groups to address allergy-related health in their workforces. Its work centers on the La Crosse Method Practice Protocol, developed by founder David L. Morris, MD, and his physician partners at Allergy Associates of La Crosse. The protocol has been in clinical use since 1970 and guides providers in treating each patient uniquely based on history, exam, and testing that identifies specific allergies and sensitivity levels. More than 2,000 providers have been educated in the protocol, and more than 275,000 patients have been treated with it.

The practice is located at 2731 National Dr, about a tenth of a mile from County Road OS. It sits roughly half a mile from Mayo Clinic Health System - Franciscan Healthcare Onalaska and about six-tenths of a mile from Gundersen Lutheran Onalaska Clinic. Elmwood Hills Park is about four-tenths of a mile away, the Mayo Clinic Health System - Franciscan Healthcare Community Garden is about three-tenths of a mile away, and Sugarloaf is about seven-tenths of a mile from the location.

Patients describe the practice in terms of effectiveness and convenience. One patient with 30 prior years of intermittent allergy shots called sublingual immunotherapy far superior in both effectiveness and convenience, including while traveling. Another reported that a son completed 29 allergens over five years. Reported outcomes include 97 percent patient adherence, 92 percent pharmacy satisfaction, and 95 percent of patients rating treatment as convenient.

For Onalaska and the surrounding region, Allergychoices brings a long-established, patient-specific approach to sublingual immunotherapy, treating the cause of allergic disease rather than its symptoms alone.